✦ LIBER ✦
High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: A retrospective investigation on 133 patients treated in a single institution
✍ Scribed by Antonio Azzarà; Giovanni Carulli; Sara Galimberti; Claudia Baratè; Rita Fazzi; Giulia Cervetti; Mario Petrini
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 308 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.